Oncology nurses do not appear to develop cancer at dramatically higher rates than other nurses or the general population, but their work does carry real biological risks. The drugs they handle daily are themselves classified as carcinogens, and measurable DNA damage has been documented in nurses who work with these medications. The concern is legitimate, even if the overall cancer numbers haven’t shown a clear spike.
What the Cancer Rates Actually Show
A 14-year study of healthcare workers in Thai cancer centers compared observed cancer cases to what would be expected in the general working population. Among female nurses and assistant nurses, the standardized incidence ratio was 1.07, meaning they developed cancer at almost exactly the rate you’d predict for any working woman their age. That ratio wasn’t statistically significant.
The more striking finding was for leukemia specifically. Across all female healthcare staff in cancer centers, leukemia occurred at more than 11 times the expected rate. That number was statistically significant, and it aligns with what scientists know about chronic exposure to drugs that damage DNA and bone marrow. Physicians in the study also showed elevated cancer rates, possibly reflecting longer careers or different exposure patterns. The takeaway: overall cancer rates in oncology nurses look roughly normal, but blood cancers may be a real outlier worth watching.
Why the Drugs Themselves Are Dangerous
Many chemotherapy drugs work by destroying DNA in cancer cells, but they can’t distinguish between a patient’s tumor and a nurse’s healthy tissue. The International Agency for Research on Cancer classifies several commonly used chemotherapy agents as known human carcinogens, the highest danger category. These include cyclophosphamide, etoposide, melphalan, and chlorambucil, among others. The 2024 NIOSH List of Hazardous Drugs in Healthcare Settings identifies over a dozen drugs in this top tier that oncology nurses may handle routinely.
These drugs cause harm through different pathways. Some form bonds directly with DNA strands, blocking the cell’s ability to copy itself correctly. Others generate reactive molecules called free radicals that shred cellular structures. Still others interfere with enzymes that help DNA unwind and repair itself. In a patient, that destruction is targeted at a tumor. In a nurse absorbing trace amounts through skin contact, inhalation, or accidental spills, the same mechanisms can quietly damage healthy cells over years.
Measurable DNA Damage in Exposed Nurses
The most concrete evidence of harm comes from studies measuring chromosomal aberrations, which are visible breaks and rearrangements in the DNA of blood cells. A meta-analysis pooling data from multiple studies found that healthcare workers exposed to chemotherapy drugs had significantly more chromosomal damage than unexposed controls, with the difference highly statistically significant (p < 0.001). One study within the analysis reported a five-fold increase in total chromosomal aberrations among exposed workers compared to controls.
Chromosomal damage doesn’t guarantee cancer, but it is a well-established precursor. Cells with broken or rearranged DNA are more likely to multiply incorrectly, and accumulation of these errors over a career is exactly the process that can lead to malignancy. This is the same type of damage seen in patients who develop secondary cancers after chemotherapy treatment, just at lower doses absorbed over a much longer timeline.
How Exposure Actually Happens
Oncology nurses don’t take chemotherapy drugs, but trace amounts end up on surfaces throughout the ward. Surface wipe studies have detected residues of drugs like 5-fluorouracil on preparation tables, even in facilities with safety protocols in place. Contamination has been found on keyboards, refrigerator doors, and countertops, sometimes in areas where drugs aren’t directly prepared.
Nurses absorb these residues primarily through skin contact and inhalation of drug particles or vapors. Touching a contaminated surface and then adjusting a face mask, eating lunch, or rubbing your eyes can transfer drugs into the body. Over the course of a shift, these tiny exposures add up. Over the course of a 20- or 30-year career, the cumulative dose becomes harder to dismiss.
Pregnancy Risks Are More Clearly Documented
While the cancer data remains somewhat ambiguous, the reproductive risks are sharper. A large study of nurses found that those working in oncology had a 13.1% spontaneous abortion rate, compared to 8.4% for medical/surgical nurses. After adjusting for age, shift work, and hours worked, nurses who handled chemotherapy drugs for one or more hours per day had roughly double the risk of miscarriage.
The risk was especially pronounced for first pregnancies. Nurses who had never been pregnant before and were exposed to these drugs faced a 3.5-fold increased risk of spontaneous abortion. The association was strongest for early pregnancy loss before 12 weeks, which fits with what’s known about DNA-damaging agents disrupting the rapid cell division of early embryonic development. These findings suggest that reproductive harm may be a more sensitive indicator of occupational exposure than cancer itself, since pregnancy loss can occur from lower cumulative doses than those needed to trigger a malignancy.
How Modern Safety Measures Reduce Risk
Hospitals have significantly improved protections over the past two decades. Closed system transfer devices, which create a sealed barrier when connecting drug vials to IV lines, are now standard in many oncology units. Testing shows these devices keep airborne drug vapor below detectable levels (under 1.0 parts per million), compared to 17 to 23 ppm without them. That’s a dramatic reduction, though no system eliminates exposure entirely.
Other protective layers include chemotherapy-rated gloves (doubled), disposable gowns, ventilated drug preparation cabinets, and spill kits. Training programs now emphasize never touching chemotherapy packaging with bare hands and decontaminating surfaces after every use. Facilities that combine all these measures consistently show lower levels of surface contamination and lower biomarker levels in staff.
The gap between best practices and real-world conditions matters, though. Understaffed shifts, rushed drug administration, inconsistent glove changes, and older facilities without ventilated cabinets all increase exposure. Nurses who work in outpatient infusion centers or home health settings may have fewer engineering controls available than those in large cancer hospitals. The protections work when they’re actually used, every time, for every drug.
What This Means for Oncology Nurses
The honest answer is that oncology nursing carries a small but real occupational hazard that is difficult to quantify precisely. Overall cancer rates in these nurses haven’t shown a dramatic increase in available studies, but the elevated leukemia risk, the documented chromosomal damage, and the clear reproductive effects all point to genuine biological consequences of exposure. The risk is almost certainly lower today than it was 30 years ago, thanks to closed transfer systems and better safety protocols, but it hasn’t been eliminated.
For nurses in the field or considering oncology as a specialty, the practical implications are straightforward: consistent use of every available protective measure matters enormously, and cutting corners on personal protective equipment during busy shifts is where the real danger lies. Nurses planning a pregnancy should discuss reassignment options with their employer, given the well-documented miscarriage risk. And facilities that invest in engineering controls, proper staffing, and regular surface monitoring are meaningfully safer workplaces than those that don’t.